ET-743 is a new class of tumor DNA binding agents with a unique mechanism of action, which can inhibit transcription-dependent nucleotide removal repair pathways in vitro and promote p53 pathway-independent apoptosis by affecting the cell cycle [12]. This evidence concerns the gene TP53 and neoplasm.